| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0001 | 1 |